NIA Caenorhabditis Interventions Testing Program (CITP) Announces Annual Call for Compounds to Test for Lifespan Extension in Caenorhabditis
National Institutes of Health (NIH)
Free. Verify your email, then we send one reminder only.
- Posted
- Apr 25, 2026
- Closes
- No deadline published by the funder
Amount
Amount not published by the funder
About this opportunity
The National Institute on Aging (NIA) Caenorhabditis Interventions Testing Program (CITP) was established to test compounds with the potential to extend lifespan and/or delay the onset of functional and physiological decline. The NIA CITP aims to identify pharmacological interventions that may moderate/alleviate health decline associated with aging in a robust manner using a genetically diverse set of Caenorhabditis strains. The CITP is comprised of four major components: three screening centers and a data coordinating center. The principal investigators at the three screening centers are (1) Monica Driscoll – Rutgers, The State University of New Jersey; (2) Patrick Phillips - University of Oregon; (3) Gordon Lithgow – Buck Institute. The data coordinating center is also headed by Patrick ...
Related opportunities
- Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)National Institutes of HealthCloses Sep 2028
- Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)National Institutes of HealthCloses in 42 days
- Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)National Institutes of HealthCloses Nov 2027
- Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)National Institutes of HealthCloses May 2028Up to $1M
- Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)National Institutes of HealthCloses Jan 2028Up to $200K
- New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)National Institutes of HealthCloses May 2027